RXR agonist 2 (Compound 22) is a highly selective agonist of the retinoid X receptor (RXR) with an EC50 of 0.039 µM. It shows potential for use in research on metabolic syndrome and Alzheimers disease.
Target:
Retinoid Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
